Fabrizio Di Costanzo
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.
Journal: Expert review of anticancer therapy
Published: June 30, 2026
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
Journal: Minerva urology and nephrology
Published: June 23, 2026
Redefining the mCRPC Frontline: Lessons from PEACE-3 and BRCAaway in the Post-ARPI Era.
Journal: The oncologist
Published: May 19, 2026
A spotlight on PTEN alterations in prostate cancer: A narrative review.
Journal: Critical reviews in oncology/hematology
Published: April 28, 2026
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.
Journal: Current oncology (Toronto, Ont.)
Published: April 22, 2026
Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.
Journal: Cancer metastasis reviews
Published: April 02, 2026
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.
Journal: Therapeutic advances in medical oncology
Published: January 26, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study.
Journal: NPJ precision oncology
Published: January 18, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.
Journal: The oncologist
Published: December 16, 2025
Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.
Journal: The oncologist
Published: December 16, 2025
Treatment options in platinum-refractory male germ cell cancers: current standards and future directions.
Journal: Therapeutic advances in medical oncology
Published: November 26, 2025
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness.
Journal: Molecular cancer therapeutics
Published: May 29, 2025
Last Updated: 09/26/2026